HUMA
Humacyte, Inc. · Healthcare
Director Brady W Dougan sold $5.6M of Humacyte, Inc.
Sold$5,560,000
$2.78Price
2,000,000Shares
−20%Stake
What HUMA did after the filing
- The stock from Fri, Sep 15 close, $3.23
- −37.9%
- S&P 500, same days
- −7.4%
Measured over 30 trading days, to the Oct 27 close.
Traded Thu, Sep 14. Filed Fri, Sep 15, 12:05 PM ET, during the session. Returns use the Sep 15 close and the Oct 27 close. Not investment advice.